Search Results | Diabetes Care | American Diabetes Association

1-20 of 251

2 3 4 5

Sort by

Sort Order Select

Journal Articles

Predictive Value of C-Peptide Measures for Clinical Outcomes of β-Cell Replacement Therapy in Type 1 Diabetes: Report From the Collaborative Islet Transplant Registry (CITR)

David A. Baidal, Cassandra M. Ballou, Michael R. Rickels, Thierry Berney, Francois Pattou, Elizabeth H. Payne, Franca B. Barton, Rodolfo Alejandro, CITR Investigators

Diabetes Care dc221155

DOI: https://doi.org/10.2337/dc22-1155

Published: 17 January 2023

View article

Journal Articles

Persistence of β-Cell Responsiveness for Over Two Years in Autoantibody-Positive Children With Marked Metabolic Impairment at Screening

Emily K. Sims, David Cuthbertson, Jamie L. Felton, Heba M. Ismail, Brandon M. Nathan, Laura M. Jacobsen, Emily Paprocki, Alberto Pugliese, Jerry Palmer, Mark Atkinson, Carmella Evans-Molina, Jay S. Skyler, Maria J. Redondo, Kevan C. Herold, Jay M. Sosenko

Diabetes Care 2022;45(12):2982–2990

DOI: https://doi.org/10.2337/dc22-1362

Published: 01 December 2022

View article

Journal Articles

Routine Islet Autoantibody Testing in Clinically Diagnosed Adult-Onset Type 1 Diabetes Can Help Identify Misclassification and the Possibility of Successful Insulin Cessation

Russell J. Eason, Nicholas J. Thomas, Anita V. Hill, Bridget A. Knight, Alice Carr, Andrew T. Hattersley, Timothy J. McDonald, Beverley M. Shields, Angus G. Jones, for the StartRight Study Group

Diabetes Care 2022;45(12):2844–2851

DOI: https://doi.org/10.2337/dc22-0623

Published: 07 October 2022

View article

Journal Articles

Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes

Randy L. Anderson, Linda A. DiMeglio, Adrian P. Mander, Colin M. Dayan, Peter S. Linsley, Kevan C. Herold, Marjana Marinac, Simi T. Ahmed

Diabetes Care 2022;45(10):2189–2201

DOI: https://doi.org/10.2337/dc22-0308

Published: 19 September 2022

View article

Journal Articles

In This Issue of Diabetes Care

Max Bingham, PhD

Diabetes Care 2022;45(10):2187–2188

DOI: https://doi.org/10.2337/dc22-ti10

Published: 19 September 2022

View article

Journal Articles

The Transition From a Compensatory Increase to a Decrease in C-peptide During the Progression to Type 1 Diabetes and Its Relation to Risk

Heba M. Ismail, David Cuthbertson, Stephen E. Gitelman, Jay S. Skyler, Andrea K. Steck, Henry Rodriguez, Mark Atkinson, Brandon M. Nathan, Maria J. Redondo, Kevan C. Herold, Carmella Evans-Molina, Linda A. DiMeglio, Jay Sosenko, on behalf of DPT-1 and TrialNet Study Groups

Diabetes Care 2022;45(10):2264–2270

DOI: https://doi.org/10.2337/dc22-0167

Published: 23 August 2022

View article

Journal Articles

Glycemic Variability Patterns Strongly Correlate With Partial Remission Status in Children With Newly Diagnosed Type 1 Diabetes

Olivier G. Pollé, Antoine Delfosse, Manon Martin, Jacques Louis, Inge Gies, Marieke den Brinker, Nicole Seret, Marie-Christine Lebrethon, Thierry Mouraux, Laurent Gatto, Philippe A. Lysy

Diabetes Care 2022;45(10):2360–2368

DOI: https://doi.org/10.2337/dc21-2543

Published: 22 August 2022

View article

Journal Articles

Neprilysin Inhibitor May Increase Urinary C-Peptide Excretion

Yuki Nishiya, Makoto Daimon, Satoru Mizushiri, Miyuki Yanagimachi, Jutaro Tanabe, Kota Matsuki, Eri Sato, Koki Matsumura

Diabetes Care 2022;45(8):e122–e123

DOI: https://doi.org/10.2337/dc22-0538

Published: 26 July 2022

View article

Journal Articles

Mechanistic Insights Into the Heterogeneity of Glucose Response Classes in Youths With Obesity: A Latent Class Trajectory Approach

Domenico Tricò, Sarah McCollum, Stephanie Samuels, Nicola Santoro, Alfonso Galderisi, Leif Groop, Sonia Caprio, Veronika Shabanova

Diabetes Care 2022;45(8):1841–1851

DOI: https://doi.org/10.2337/dc22-0110

Published: 26 July 2022

View article

Journal Articles

Measures of Insulin Resistance as a Screening Tool for Dysglycemia in Patients With Coronary Artery Disease: A Report From the EUROASPIRE V Population

Giulia Ferrannini, Dirk De Bacquer, Iris Erlund, Viveca Gyberg, Kornelia Kotseva, Linda Mellbin, Anna Norhammar, Oliver Schnell, Jaakko Tuomilehto, Terhi Vihervaara, David Wood, Lars Rydén

Diabetes Care 2022;45(9):2111–2117

DOI: https://doi.org/10.2337/dc22-0272

Published: 30 June 2022

View article

Journal Articles

An Atypical Form of Diabetes Among Individuals With Low BMI

Diabetes Care 2022;45(6):1428–1437

DOI: https://doi.org/10.2337/dc21-1957

Published: 27 May 2022

View article

Journal Articles

Exendin-(9-39) Effects on Glucose and Insulin in Children With Congenital Hyperinsulinism During Fasting and During a Meal and a Protein Challenge

Darko Stefanovski, Mary E. Vajravelu, Stephanie Givler, Diva D. De León

Diabetes Care 2022;45(6):1381–1390

DOI: https://doi.org/10.2337/dc21-2009

Published: 13 April 2022

View article

Journal Articles

Predictors of Glycemic Outcomes at 1 Year Following Pediatric Total Pancreatectomy With Islet Autotransplantation

Sarah E. Swauger, Lindsey N. Hornung, Deborah A. Elder, Appakalai N. Balamurugan, David S. Vitale, Tom K. Lin, Jaimie D. Nathan, Maisam Abu-El-Haija

Diabetes Care 2022;45(2):295–302

DOI: https://doi.org/10.2337/dc21-1222

Published: 17 January 2022

View article

Journal Articles

Comment on Meek et al. Reappearance of C-Peptide During the Third Trimester of Pregnancy in Type 1 Diabetes: Pancreatic Regeneration or Fetal Hyperinsulinism? Diabetes Care 2021;44:1826–1834

Marina Ivanisevic, Josip Djelmis

Diabetes Care 2022;45(2):e41–e42

DOI: https://doi.org/10.2337/dc21-2072

Published: 17 January 2022

View article

Journal Articles

Response to Comment on Meek et al. Reappearance of C-Peptide During the Third Trimester in Type 1 Diabetes Pregnancy: Pancreatic Regeneration or Fetal Hyperinsulinism? Diabetes Care 2021;44:1826–1834

Claire L. Meek, Richard A. Oram, Timothy J. McDonald, Denice S. Feig, Andrew T. Hattersley, Helen R. Murphy

Diabetes Care 2022;45(2):e43–e44

DOI: https://doi.org/10.2337/dci21-0054

Published: 17 January 2022

View article

Journal Articles

Index60 Identifies Individuals at Appreciable Risk for Stage 3 Among an Autoantibody-Positive Population With Normal 2-Hour Glucose Levels: Implications for Current Staging Criteria of Type 1 Diabetes

Brandon M. Nathan, Maria J. Redondo, Heba Ismail, Laura Jacobsen, Emily K. Sims, Jerry Palmer, Jay Skyler, Laura Bocchino, Susan Geyer, Jay M. Sosenko

Diabetes Care 2022;45(2):311–318

DOI: https://doi.org/10.2337/dc21-0944

Published: 01 December 2021

View article

Journal Articles

Development and Progression of Diabetic Retinopathy in Adolescents and Young Adults With Type 2 Diabetes: Results From the TODAY Study

TODAY Study Group

Diabetes Care 2022;45(5):1049–1055

DOI: https://doi.org/10.2337/dc21-1072

Published: 16 September 2021

View article

Journal Articles

Effects of Metabolic Factors, Race-Ethnicity, and Sex on the Development of Nephropathy in Adolescents and Young Adults With Type 2 Diabetes: Results From the TODAY Study

TODAY Study Group

Diabetes Care 2022;45(5):1056–1064

DOI: https://doi.org/10.2337/dc21-1085

Published: 16 September 2021

View article

Journal Articles

TCF7L2 Genetic Variants Do Not Influence Insulin Sensitivity or Secretion Indices in Autoantibody-Positive Individuals at Risk for Type 1 Diabetes

Maria J. Redondo, Megan V. Warnock, Ingrid M. Libman, Laura E. Bocchino, David Cuthbertson, Susan Geyer, Alberto Pugliese, Andrea K. Steck, Carmella Evans-Molina, Dorothy Becker, Jay M. Sosenko, Fida Bacha, the Type 1 Diabetes TrialNet Study Group

Diabetes Care 2021;44(9):2039–2044

DOI: https://doi.org/10.2337/dc21-0531

Published: 26 August 2021

View article

Journal Articles

Reappearance of C-Peptide During the Third Trimester of Pregnancy in Type 1 Diabetes: Pancreatic Regeneration or Fetal Hyperinsulinism?

Claire L. Meek, Richard A. Oram, Timothy J. McDonald, Denice S. Feig, Andrew T. Hattersley, Helen R. Murphy

Diabetes Care 2021;44(8):1826–1834

DOI: https://doi.org/10.2337/dc21-0028

Published: 26 June 2021

View article

2 3 4 5

NARROW

Predictive Value of C-Peptide Measures for Clinical Outcomes of β-Cell Replacement Therapy in Type 1 Diabetes: Report From the Collaborative Islet Transplant Registry (CITR)

Persistence of β-Cell Responsiveness for Over Two Years in Autoantibody-Positive Children With Marked Metabolic Impairment at Screening

Routine Islet Autoantibody Testing in Clinically Diagnosed Adult-Onset Type 1 Diabetes Can Help Identify Misclassification and the Possibility of Successful Insulin Cessation

Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes

In This Issue of Diabetes Care

The Transition From a Compensatory Increase to a Decrease in C-peptide During the Progression to Type 1 Diabetes and Its Relation to Risk

Glycemic Variability Patterns Strongly Correlate With Partial Remission Status in Children With Newly Diagnosed Type 1 Diabetes

Neprilysin Inhibitor May Increase Urinary C-Peptide Excretion

Mechanistic Insights Into the Heterogeneity of Glucose Response Classes in Youths With Obesity: A Latent Class Trajectory Approach

Measures of Insulin Resistance as a Screening Tool for Dysglycemia in Patients With Coronary Artery Disease: A Report From the EUROASPIRE V Population

An Atypical Form of Diabetes Among Individuals With Low BMI

Exendin-(9-39) Effects on Glucose and Insulin in Children With Congenital Hyperinsulinism During Fasting and During a Meal and a Protein Challenge

Predictors of Glycemic Outcomes at 1 Year Following Pediatric Total Pancreatectomy With Islet Autotransplantation

Comment on Meek et al. Reappearance of C-Peptide During the Third Trimester of Pregnancy in Type 1 Diabetes: Pancreatic Regeneration or Fetal Hyperinsulinism? Diabetes Care 2021;44:1826–1834

Response to Comment on Meek et al. Reappearance of C-Peptide During the Third Trimester in Type 1 Diabetes Pregnancy: Pancreatic Regeneration or Fetal Hyperinsulinism? Diabetes Care 2021;44:1826–1834

Index60 Identifies Individuals at Appreciable Risk for Stage 3 Among an Autoantibody-Positive Population With Normal 2-Hour Glucose Levels: Implications for Current Staging Criteria of Type 1 Diabetes

Development and Progression of Diabetic Retinopathy in Adolescents and Young Adults With Type 2 Diabetes: Results From the TODAY Study

Effects of Metabolic Factors, Race-Ethnicity, and Sex on the Development of Nephropathy in Adolescents and Young Adults With Type 2 Diabetes: Results From the TODAY Study

TCF7L2 Genetic Variants Do Not Influence Insulin Sensitivity or Secretion Indices in Autoantibody-Positive Individuals at Risk for Type 1 Diabetes

Reappearance of C-Peptide During the Third Trimester of Pregnancy in Type 1 Diabetes: Pancreatic Regeneration or Fetal Hyperinsulinism?

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only